HPR120 Negotiating New Therapeutic Indications in Italy: Which Impact on Drug Reimbursement Conditions and Timing?
Abstract
Authors
L Candelora B Canali C Fattore F Fiorentino P La Malfa B Manini D Urbinati
L Candelora B Canali C Fattore F Fiorentino P La Malfa B Manini D Urbinati
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now